Abstract

2′-fucosyllactose (2′-FL), one of the simplest but most abundant oligosaccharides in human milk, has been demonstrated to have many positive benefits for the healthy development of newborns. However, the high-cost production and limited availability restrict its widespread use in infant nutrition and further research on its potential functions. In this study, on the basis of previous achievements, we developed a powerful cell factory by using a lacZ-mutant Escherichia coli C41 (DE3)ΔZ to ulteriorly increase 2′-FL production by feeding inexpensive glycerol. Initially, we co-expressed the genes for GDP-L-fucose biosynthesis and heterologous α-1,2-fucosyltransferase in C41(DE3)ΔZ through different plasmid-based expression combinations, functionally constructing a preferred route for 2′-FL biosynthesis. To further boost the carbon flux from GDP-L-fucose toward 2′-FL synthesis, deletion of chromosomal genes (wcaJ, nudD, and nudK) involved in the degradation of the precursors GDP-L-fucose and GDP-mannose were performed. Notably, the co-introduction of two heterologous positive regulators, RcsA and RcsB, was confirmed to be more conducive to GDP-L-fucose formation and thus 2′-FL production. Further a genomic integration of an individual copy of α-1,2-fucosyltransferase gene, as well as the preliminary optimization of fermentation conditions enabled the resulting engineered strain to achieve a high titer and yield. By collectively taking into account the intracellular lactose utilization, GDP-L-fucose availability, and fucosylation activity for 2′-FL production, ultimately a highest titer of 2′-FL in our optimized conditions reached 6.86 g/L with a yield of 0.92 mol/mol from lactose in the batch fermentation. Moreover, the feasibility of mass production was demonstrated in a 50-L fed-batch fermentation system in which a maximum titer of 66.80 g/L 2′-FL was achieved with a yield of 0.89 mol 2′-FL/mol lactose and a productivity of approximately 0.95 g/L/h 2′-FL. As a proof of concept, our preliminary 2′-FL production demonstrated a superior production performance, which will provide a promising candidate process for further industrial production.

Highlights

  • Breast-feeding has long been considered the preferred option for infant nutrition, since human milk contains a large number of bioactive nutrients that are not available and indispensable (Bode, 2012)

  • E. coli C41 (DE3) Z deficient in β-galactosidase was previously constructed by Dr Jinyong Wu in our laboratory, and used as the host strains for 2′-FL production in this study

  • The knockout of nudD gene generated an improved GDP-L-fucose concentration in C41 ZWK/pR (Supplementary Figure 3), and a maximum titer of 2′-FL was appreciably increased to 3.55 g/L (Figure 3B), which was 23.7% higher than that detected in the control strain C41 ZW/pR

Read more

Summary

Introduction

Breast-feeding has long been considered the preferred option for infant nutrition, since human milk contains a large number of bioactive nutrients that are not available and indispensable (Bode, 2012). Therein, human milk oligosaccharides (HMOs) provide a wide range of biological functions for infant care, for instance, improvement of infant digestion and intestinal development, promotion of infant brain development, and immune maturation (Bode, 2012; Donovan and Comstock, 2016; Reverri et al, 2018). As a naturally-occurring ingredient with a high content in human breast milk, 2′-FL is almost absent in cow’s milk which is the most commonly used raw material for infant formula (Petschacher and Nidetzky, 2016). Industrial 2′-FL production cost-effectively has attracted more and more attention, and has become the focus of competition in patent protection worldwide

Methods
Findings
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call